ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Phase 3 Extension Study of Dexpramipexole in ALS

ClinicalTrials.gov ID: NCT01622088

Public ClinicalTrials.gov record NCT01622088. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 14, 2026, 10:14 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Dexpramipexole (BIIB050) in Subjects With Amyotrophic Lateral Sclerosis

Study identification

NCT ID
NCT01622088
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Knopp Biosciences
Industry
Enrollment
616 participants

Conditions and interventions

Interventions

  • Dexpramipexole Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2012
Primary completion
Jan 31, 2013
Completion
Jan 31, 2013
Last update posted
May 2, 2022

2012 – 2013

United States locations

U.S. sites
42
U.S. states
27
U.S. cities
41
Facility City State ZIP Site status
Barrow Neurological Institute - St. Joseph's Hospital Phoenix Arizona 85013
University of California at San Francisco - Fresno Fresno California 03721
University of California, Irvine Orange California 92868
University of California, Davis Sacramento California 95817
California Pacific Medical Center San Francisco California 94115
Hospital for Special Care New Britain Connecticut 06053
Mayo Clinic - Jacksonville Jacksonville Florida 32224
University of Miami Miller School of Medicine Miami Florida 33136
University of South Florida Medical Center Tampa Florida 33612
Emory University Atlanta Georgia 30322
Northwestern University Chicago Illinois 60611
Indiana University Indianapolis Indiana 46202
University of Iowa Iowa City Iowa 52242
University of Kansas Medical Center Kansas City Kansas 66160
Johns Hopkins University School of Medicine Baltimore Maryland 21287
Massachusetts General Hospital Charlestown Massachusetts 02129
St. Mary's Health Care Grand Rapids Michigan 49503
Hennepin County Medical Center Minneapolis Minnesota 55404
Mayo Clinic - Rochester Rochester Minnesota 55905
Washington University School of Medicine St Louis Missouri 63110
Neurology Associates, P.C. Lincoln Nebraska 68506
University of Nevada School of Medicine Las Vegas Nevada 89102
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03756
Columbia University New York New York 10032
Research Foundation of the State University of New York Syracuse New York 12207
Carolinas Medical Center Charlotte North Carolina 28207
Duke University Medical Center Durham North Carolina 27705
Wake Forest University Winston-Salem North Carolina 27157
The Cleveland Clinic Foundation Cleveland Ohio 44195
Ohio State University Columbus Ohio 43210
Providence ALS Center Portland Oregon 97213
Penn State Hershey Medical Center Hershey Pennsylvania 17033
Drexel University College of Medicine Philadelphia Pennsylvania 19102
ALS Center at Penn Philadelphia Pennsylvania 19107
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213
Vanderbilt University Medical Center Nashville Tennessee 37232
Texas Neurology Dallas Texas 75214
Methodist Neurological Institute Houston Texas 77030
University of Texas Health Sciences Center San Antonio Texas 78229
University of Utah Salt Lake City Utah 84132
University of Virginia Health System Charlottesville Virginia 22908
University of Washington Seattle Washington 98195

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01622088, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 2, 2022 · Synced May 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01622088 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →